| __timestamp | Merck & Co., Inc. | Supernus Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 25469000000 | 116287000 |
| Thursday, January 1, 2015 | 24564000000 | 136004000 |
| Friday, January 1, 2016 | 25916000000 | 203017000 |
| Sunday, January 1, 2017 | 27347000000 | 287023000 |
| Monday, January 1, 2018 | 28785000000 | 393541000 |
| Tuesday, January 1, 2019 | 32728000000 | 376095000 |
| Wednesday, January 1, 2020 | 27900000000 | 467938000 |
| Friday, January 1, 2021 | 35078000000 | 504714000 |
| Saturday, January 1, 2022 | 41872000000 | 580017000 |
| Sunday, January 1, 2023 | 43989000000 | 523742000 |
Cracking the code
In the ever-evolving pharmaceutical industry, the financial health of companies is a key indicator of their market position and potential for innovation. Over the past decade, Merck & Co., Inc. has consistently demonstrated robust growth in gross profit, with a remarkable increase of approximately 73% from 2014 to 2023. This growth underscores Merck's strategic prowess and its ability to capitalize on market opportunities.
In contrast, Supernus Pharmaceuticals, Inc., while significantly smaller, has shown a steady upward trajectory in its gross profit, growing nearly fivefold over the same period. This growth highlights Supernus's potential in niche markets and its commitment to expanding its product portfolio.
The data from 2014 to 2023 paints a vivid picture of two companies on different scales but both making significant strides in their respective domains.
Merck & Co., Inc. and Novartis AG: A Detailed Gross Profit Analysis
Gross Profit Analysis: Comparing Merck & Co., Inc. and AstraZeneca PLC
Gross Profit Trends Compared: Merck & Co., Inc. vs Biogen Inc.
Merck & Co., Inc. and Pharming Group N.V.: A Detailed Gross Profit Analysis
Gross Profit Trends Compared: Merck & Co., Inc. vs Halozyme Therapeutics, Inc.
Key Insights on Gross Profit: Merck & Co., Inc. vs Evotec SE
Who Generates Higher Gross Profit? Alnylam Pharmaceuticals, Inc. or Supernus Pharmaceuticals, Inc.
Gross Profit Trends Compared: Catalent, Inc. vs Supernus Pharmaceuticals, Inc.
Ascendis Pharma A/S vs Supernus Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Gross Profit Comparison: Amneal Pharmaceuticals, Inc. and Supernus Pharmaceuticals, Inc. Trends
Gross Profit Comparison: Ligand Pharmaceuticals Incorporated and Supernus Pharmaceuticals, Inc. Trends
Who Generates Higher Gross Profit? Supernus Pharmaceuticals, Inc. or BioCryst Pharmaceuticals, Inc.